Home / ORCHPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ORCHPHARMA.NS make money? Does ORCHPHARMA.NS have pricing power? What's the Earnings Whisper? Will ORCHPHARMA.NS profit more as the business scales? What is ORCHPHARMA.NS's management track record? Is ORCHPHARMA.NS's current price justified?

Orchid Pharma Limited

₹911.25 +$118.10 (+14.89%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹928.05

Day Range

₹896₹938.95

Year Range

₹480₹1143.5

Market Cap

46.22B

AVG Volume

168.66K

Trailing/Forward PE

532.89/21.49

PEG ratio

1.33

Dividend Yield

Next Earnings Date

2026-11-16

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

ORCHPHARMA.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	3.04B
26 Q4	2.38B
26 Q3	2.07B
26 Q2	1.94B
26 Q1	1.73B
25 Q4	2.37B
25 Q3	2.17B
25 Q2	2.23B
25 Q1	2.44B
24 Q4	2.17B

Net Income (INR) · Q

ORCHPHARMA.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	32.24M
26 Q4	237.8M
26 Q3	-126.14M
26 Q2	-57.24M
26 Q1	149.11M
25 Q4	222.95M
25 Q3	207.75M
25 Q2	272.37M
25 Q1	293.51M
24 Q4	335.27M

Operating Income (INR) · Q

ORCHPHARMA.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	30.51M
26 Q4	179.97M
26 Q3	309.63M
26 Q2	-103.77M
26 Q1	55.21M
25 Q4	191.12M
25 Q3	618.88M
25 Q2	217.13M
25 Q1	240.48M
24 Q4	204.98M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Orchid Pharma Limited

Video analysis: ORCHPHARMA.NS

News: ORCHPHARMA.NS

Similar companies